胆管细胞癌中发现致密核心颗粒。
We found electron-dense core granules in cytoplasm of cholangiocarcinoma.
目的探讨肝内胆管细胞癌的螺旋CT表现。
Objective To explore the ct features of intrahepatic cholangiocarcinoma.
国际肝病：肝内胆管细胞癌是高致死性疾病，治疗手段也有限。
Heptology Digest: Intrahepatic Cholangiocarcinoma is a highly fatal disease with limited therapeutic options.
目的：探讨多排螺旋CT (MSCT)对胆管细胞癌诊断的价值。
Objective: To evaluate the value of MSCT in the diagnosis of cholangiocarcinoma.
目的根据原发性肝内周围型胆管细胞癌的CT表现，探讨其诊断价值。
Objective Accoding to the ct findings of primary intrahepatic peripheral cholangiocarcinoma (PIHPCC), we probe into its? Diagnostic value.
结论：多排螺旋CT诊断胆管细胞癌比单螺旋CT具有较高的准确率。
Conclusions: MSCT scan is superior to SSCT in diagnosis of cholangiocarcinoma.
目的：探讨胆管内生长型肝内胆管细胞癌(IICC)的CT表现特征。
Objective: To investigate the ct features of intrahepatic intraductal cholangiocarcinoma (IICC).
摘要：目的利用氢质子磁共振波谱分析肝细胞癌和胆管细胞癌代谢物变化。
ABSTRACT: Objective to investigate the value of in vivo proton magnetic resonance spectroscopy (1h MRS) in the assessment of hepatocellular carcinoma (HCC) and cholangiocarcinoma.
方法分析研究经病理证实的47例原发性肝内周围型胆管细胞癌的CT表现。
Methods CT appearances of primary intrahepatic peripheral cholangiocarcinoma proved by histologically in 47 cases were analyzed.
方法：12例经病理证实周围型胆管细胞癌的常规ct平扫及CT增强扫描。
Method: 12 are strengthened the scanning by routine CT flat sweeping and CT that pathology verify the intrahepatic peripheral cholangiocarcinoma.
方法对来我院就诊经手术病理证实的8例肝内胆管细胞癌的CT资料进行分析。
Methods to come my hospital treatment by surgery and pathology confirmed 8 cases of intrahepatic cholangiocarcinoma of the CT data analysis.
目的提高肝内胆管细胞癌的诊断和治疗水平，分析其临床特点及预后相关因素。
ObjectiveTo improve the diagnosis and treatment of the cholangiocarcinoma and analyze the clinical characteristics and the prognosis.
目的探讨肝内胆管细胞癌的螺旋CT动态增强表现及与其他肝内肿瘤的鉴别要点。
Objective To investigate the intrahepatic cholangiocarcinoma of dynamic contrast-enhanced spiral ct performance and identification with the other elements of liver tumors.
目的：比较表皮生长因子受体(EGFR)在肝细胞癌及胆管细胞癌中表达的差异。
Purpose to explore the difference in the expression of epidermal growth factor receptor (EGFR) between hepatocellular carcinoma and cholangiocarcinoma.
结论：肝内胆管细胞癌cd 151表达与其恶性表型相关，可能参与其侵袭和转移。
Conclusions: The overexpression of CD151 was correlated with malignant phenotype of intra hepatic cholangiocarcinoma and probably implicated in invasion and metastasis.
结论早期诊断和早期治疗以及规则性肝切除是改善肝内胆管细胞癌外科治疗效果的关键因素。
Conclusions Early diagnosis and treatment and major hepatectomy are key points for improving the results of the surgical therapy for patients with ICC.
此外，发现支气管腺癌、甲状腺嗜酸性腺瘤、甲状腺髓样癌和胆管细胞癌S-100蛋白阳性。
Especially, we have demonstrated S-100 protein in eosinophilic adenoma and medullary carcinoma of thyroid gland, adenocarcinoma of bile duct and bronchiolar adenocarcinoma.
结论原发性肝内周围型胆管细胞癌ct表现有一定的特征性，对于该病的诊断与肝内其他病变的鉴别有重要价值。
Conclusion the CT-features of primary intrahepatic peripheral cholangiocarcinoma are of certain characteristic, and it has important value? For diagnosis on the disease? And the others in liver.
胆管癌不产生胆汁，但这些细胞生成粘蛋白，并很难与活检或针吸标本的转移性腺癌相区分。
Cholangiocarcinomas do not make bile, but the cells do make mucin, and they can be almost impossible to distinguish from metastatic adenocarcinoma on biopsy or fine needle aspirate.
方法将人肝门部胆管癌标本进行细胞培养，传代。
Methods The fresh human hilar cholangiocarcinoma specimen was cultured.
肝内胆管癌中的透明细胞亚型是相当罕见的，到现在，仅有8例被报道。
The clear cell subtype of ICC is a rare cancer; until now, only 8 cases have been reported.
方法回顾性收集749例阻塞性黄疸的临床资料，对其中18例经手术、病理证实为肝细胞癌胆管转移的影像资料进行分析。
Methods the clinical data of 749 cases with obstructive jaundice were collected retrospectively, and among them 18 cases of HCBDM, identified by operation and pathology were analysed.
其中肝细胞性肝癌77例(84.6%)，胆管癌9例(9.9%)，混合细胞性肝癌2例(2.2%)和肝母细胞瘤3例(3.3%)。
Among all the cases studies, 77 (84.6%) were of hepatocellular carcinoma, 9 (9.9%) of cholangiocarcinoma, 2 (2.2%) of mixed cell carcinoma, and 3 (3.3%;) of hepatoblastoma.
其中肝细胞性肝癌77例(84.6%)，胆管癌9例(9.9%)，混合细胞性肝癌2例(2.2%)和肝母细胞瘤3例(3.3%)。
Among all the cases studies, 77 (84.6%) were of hepatocellular carcinoma, 9 (9.9%) of cholangiocarcinoma, 2 (2.2%) of mixed cell carcinoma, and 3 (3.3%;) of hepatoblastoma.
应用推荐